Oscar Health, Inc. (OSCR)
NYSE NYSE Primary 
Oscar Health, Inc. (OSCR) Increases Despite Market Slip: Here's What You Need to Know
In the most recent trading session, Oscar Health, Inc. (OSCR) closed at $13.61, indicating a +1.8% shift from the previous trading day.
Why Oscar Health, Inc. (OSCR) Outpaced the Stock Market Today
In the closing of the recent trading day, Oscar Health, Inc. (OSCR) stood at $14.19, denoting a +1.65% change from the preceding trading day.
Is Trending Stock Oscar Health, Inc. (OSCR) a Buy Now?
Oscar Health (OSCR) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Oscar Health, Inc. (OSCR) Advances But Underperforms Market: Key Facts
The latest trading day saw Oscar Health, Inc. (OSCR) settling at $12.85, representing a +0.16% change from its previous close.
Oscar Health, Inc. (OSCR) Laps the Stock Market: Here's Why
Oscar Health, Inc. (OSCR) reachead $13.45 at the closing of the latest trading day, reflecting a +1.74% change compared to its last close.
Here's how Oscar Health CEO Mark Bertolini wants to fix the health insurance system
Mark Bertolini, Oscar Health CEO and former Aetna chairman and CEO, discusses potential solutions to some of the problems in the health insurance industry and why he believes the individual insurance market is the solution for Americans.
Oscar Health CEO on fixing the health insurance system: Individual insurance market is the solution
Mark Bertolini, Oscar Health CEO and former Aetna chairman and CEO, joins 'Squawk Box' to discuss potential solutions to some of the problems in the health insurance industry, why he believes the individual insurance market is the solution for Americans, and more.
Oscar Health: The Most Undervalued Small Cap But With One Big Risk
I am bullish on Oscar Health (OSCR) due to its efficient D2C model, AI integration, and improving EBITDA margins despite high revenue growth. OSCR's opportunity in the ICHRA market is significant, with projections to increase 3x-5x by 2030, positioning it well against larger competitors. Risks include potential changes to ACA subsidies under future administrations, which could disrupt OSCR's current business model and force a shift to ICHRA.
Michael Burry's latest stock bet is skyrocketing
Michael Burry of ‘The Big Short' fame earned the admiration of investors all over the world by correctly predicting and profiting off of the 2008 subprime mortgage crisis.
Oscar Health, Inc. (OSCR) Q4 2024 Earnings Call Transcript
Oscar Health, Inc. (NYSE:OSCR ) Q4 2024 Earnings Conference Call February 4, 2025 5:00 PM ET Company Participants Chris Potochar – Vice President of Treasury and Investor Relations Mark Bertolini – Chief Executive Officer Scott Blackley – Chief Financial Officer Conference Call Participants Stephen Baxter – Wells Fargo Josh Raskin – Nephron Research Michael Ha – Baird Jonathan Yong – UBS Jessica Tassan – Piper Sandler Adam Ron – Bank of America Operator Good evening. My name is Rob, and I will be your conference operator today.
Oscar Health Reports First Profitable Year as Digital Mix Drives Engagement
The U.S. healthcare sector has undergone a rapid digital transformation in recent years, driven by a combination of regulatory shifts, consumer demand and technological advancements. The pandemic accelerated the adoption of telemedicine, remote monitoring and artificial intelligence (AI)-driven diagnostics, making digital health an essential component of modern care delivery.
Oscar Health, Inc. (OSCR) Reports Q4 Loss, Lags Revenue Estimates
Oscar Health, Inc. (OSCR) came out with a quarterly loss of $0.62 per share versus the Zacks Consensus Estimate of a loss of $0.58. This compares to loss of $0.66 per share a year ago.
